39584
3-Sulfopyruvic acid lithium salt hydrate
≥97.0% (TLC)
Synonym(s):
2-Oxo-3-sulfopropanoic acid lithium salt hydrate, Lithium 3-sulfopyruvate hydrate
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Empirical Formula (Hill Notation):
C3H4O6S
Molecular Weight:
168.13
NACRES:
NA.24
PubChem Substance ID:
UNSPSC Code:
41116107
MDL number:
InChI key
BUTHMSUEBYPMKJ-UHFFFAOYSA-N
SMILES string
O=C(C(O)=O)CS(=O)(O)=O
InChI
1S/C3H4O6S/c4-2(3(5)6)1-10(7,8)9/h1H2,(H,5,6)(H,7,8,9)
grade
analytical standard
assay
≥97.0% (TLC)
impurities
≤15% water
format
neat
storage temp.
2-8°C
Quality Level
Biochem/physiol Actions
3-Sulfopyruvic acid is the product of the transamination of cysteinesulfonate in a reaction catalyzed by aspartate amino- transferase. 3-Sulfopyruvic acid is stable and is reduced by malate dehydrogenase to beta-sulfolactate, which is excreted in the urine. Cysteinesulfonate, 3-sulfo- pyruvic acid, and beta-sulfolactate are reversibly interconverted in vivo.
Storage Class
13 - Non Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Signaling And Metabolism In Cancer: Endocrine Pancreas Deficiency And Hybrid Anabolism - Catabolism, Drugs That Undo The Process
Israel, M.
Cancer Therapy, 10, 1-1 (2014)
Mammalian sulfur amino acid metabolism: an overview.
O W Griffith
Methods in enzymology, 143, 366-376 (1987-01-01)
C L Weinstein et al.
The Journal of biological chemistry, 263(8), 3735-3743 (1988-03-15)
L-Cysteinesulfonate (L-cysteate) is present in plasma, urine, and tissues in concentrations comparable to that of L-cysteinesulfinate, the primary oxidative metabolite of L-cysteine. Although cysteinesulfonate is known to be decarboxylated to taurine by cysteinesulfinate decarboxylase, the occurrence and importance of other
Three rare diseases in one Sib pair: RAI1, PCK1, GRIN2B mutations associated with Smith-Magenis Syndrome, cytosolic PEPCK deficiency and NMDA receptor glutamate insensitivity.
Adams DR, Yuan H, Holyoak T, et al.
Molecular Genetics and Metabolism, 113(3), 161-170 (2014)
Molecular properties of dihydropyridine-sensitive calcium channels in skeletal muscle.
W A Catterall et al.
The Journal of biological chemistry, 263(8), 3535-3538 (1988-03-15)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service